πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,639 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7700651

Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for th

The Board of Regents of the University of Texas System Β· Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7696306

Compositions and methods for preventing or treating cancer

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue Apr 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7691832

Methods of treatment of inflammatory diseases

The Board of Regents of the University of Oklahoma Β· Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7691567

Methods and compositions relating to fortilin, an anti-apoptotic molecule, and modulators

The Board of Regents of the University of Texas System Β· Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7691380

Combined methods for tumor coagulation and tumor treatment

The Board of Regents of the University of Texas System Β· Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7678386

Liposomes coated with selected antibodies that bind to aminophospholipids

The Board of Regents of the University of Texas Β· Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7670767

Genetic alterations associated with cancer

The Board of Regents of the University of Texas System Β· Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7670600

Molecules with extended half-lives, compositions and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7659306

Method of increasing gastric emptying

The Board of Regents of the University of Texas System Β· Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7659071

Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, i

The Board of Regents of the University of Texas System Β· Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7658923

Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing C

The Board of Regents of the University of Texas System Β· Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7655241

Methods and compositions for vaccination against or involving enterobacteriaceae bacteria

The Board of Regents of the University of Texas System Β· Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7645732

Treating hepatitis C virus infection

The Board of Regents of the University of Texas System Β· Granted Tue Jan 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7642234

Beta-2-glycoprotein 1 is an inhibitor of angiogenesis

The Board of Regents of the University of Texas System Β· Granted Tue Jan 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 31 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7638678

Animal model for perimenopause and menopause and methods of inducing ovarian failure

THE ARIZONA BOARD OF REGENTS Β· Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7638544

Dimeric small molecule potentiators of apoptosis

The Board of Regents of the University of Texas System Β· Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7638507

Compositions for treatment of inflammatory diseases

The Board of Regents of the University of Oklahoma Β· Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7638284

Immunoglobulin A inducing protein and uses therefor

The Board of Regents of the University of Texas Β· Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7638282

Genes of an otitis media isolate of nontypeable Haemophilus influenzae

The Board of Regents of the University of Oklahoma Β· Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7638135

Collagen-binding proteins from enterococcal bacteria

The Board of Regents of the University of Texas System Β· Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7632502

Cell wall mannoproteins and active epitopes from Candida albicans and antibodies recognizi

The Board of Regents of the University of Texas System Β· Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7632484

Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific dise

The Board of Regents of the University of Texas System Β· Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7627938

Tapered hollow metallic microneedle array assembly and method of making and using the same

The Board of Regents of the University of Texas System Β· Granted Tue Dec 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7629308

Methods relating to muscle selective calcineurin interacting protein (MCIP)

The Board of Regents of the University of Texas System Β· Granted Tue Dec 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted